Skip to content

Tectonic Therapeutics TECX Operating Lease Right-of-Use Assets in Other Assets

Operating Lease Right-of-Use Assets in Other Assets at other companies

ALN
Alnylam PharmaceuticalsALNY
Septerna, Inc. logo
Septerna, Inc.SEPN
Regenxbio logo
RegenxbioRGNX
Opko Health logo
Opko HealthOPK
Ginkgo Bioworks logo
Ginkgo BioworksDNA
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL

Other financials

Income statement

See full
Operating income-$27.3M-49.2%
Net income-$25.2M-58.7%
EPS (diluted)-$1.34-44.1%

Balance sheet

See full
Cash & equivalents$236.9M-22.8%
Total debt$4.9M+86.1%
Total equity$230.4M-23.5%
Total assets$246.6M-21.7%

Cash flow

See full
Operating cash flow-$18.4M-40.7%
CapEx$19.0K-29.6%
Free cash flow-$18.4M-40.6%

Valuation

See full
Market cap$585.51M+58.3%
Enterprise value$353.51M+438%

Returns & leverage

See full
Return on equity-31.4%
Debt / equity0.0×
Current ratio18.5×-4.4×

Where this comes from

Reported directly by Tectonic Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Tectonic Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tectonic Therapeutics's operating lease right-of-use assets in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tectonic Therapeutics's operating lease right-of-use assets in other assets?
Tectonic Therapeutics (TECX) reported operating lease right-of-use assets in other assets of $4.11M in Q1 2026.
How has Tectonic Therapeutics's operating lease right-of-use assets in other assets changed year-over-year?
Tectonic Therapeutics's operating lease right-of-use assets in other assets increased by 138.3% year-over-year, from $1.72M to $4.11M.